The company has also completed a Phase Ib trial testing its first-in-class neurogenic compound, NSI-189, in patients with major depressive disorder .
http://ift.tt/1gwsk8P
http://ift.tt/1gwsk8P
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment